Figure 1. Ultrasound monitoring showing
shower of tinny clots (microemboli) flowing in the brain vessel.
Stroke is the second leading cause of death
and the commonest cause of disability among the Chinese. More importantly, stroke is
more common in the Chinese than in the Caucasians. Yet there were few data to confirm
if there were any true ethnic differences in the cause of stroke between the East and the
West. With the support of the RGC, we were the first in the world to confirm that narrowing
of the blood vessels around the brain was the commonest cause of stroke in the Chinese,
in contrast to previous studies that showed narrowing of the blood vessel in the neck
region was the commonest cause in the Caucasians. The same observation was later
confirmed in other Asian populations such as the Thai, Korean, Malaysian and Indian.
Moreover, we discovered that the total burden of the narrowed vessel could predict the
risk of further stroke among stroke survivors. We thought it would be a good idea if we
could identify subjects with narrowed vessels before they developed stroke. We were first in
the world to document that 7-8% of normal subjects aged >40 harboured brain narrowed
brain vessel without knowing it. A study of > 3,000 subjects at the United Christian Hospital
and the Prince of Wales Hospital medical clinics found that the risk of harbouring
asymptomatic narrowed brain vessels were directly related to the number of risk factors
present in an individual. These subjects with narrowed vessels were at double the risk
for future stroke and deaths despite medical treatment. The next step of our projects aimed
to elucidate the underlying mechanisms why narrowed vessels caused stroke. Using
ultrasound monitoring of the blood flow in the brain vessels, we were able to detect tinny
clots flowing in the blood vessels because the clots reflected more ultrasound energy
than the normal red blood cells. Combining the results of the state-of-the-art magnetic
resonance imaging and ultrasound, we found that narrowed vessels commonly produced
stroke by releasing blood clots into the distal blood vessels and then occluding these vessels
downstream. We were able to show that the amount of tinny blood clots released from the
narrowed vessels predicted the amount of dead brain cells and also predicted the risk of
further stroke, especially in the immediate few days after the first stroke. All these observations
added on our understanding of the underlying mechanisms of stroke
in the Chinese and provided the basis for more aggressive
treatment of patients with recent stroke. Because the tinny blood clots in the circulation
consisted mainly of platelet aggregation, we compared the effect of
double anti-platelet drugs with just one anti-platelet
drug in 100 patients with recent stroke and flowing blood clots. We found
that double anti-platelet drug reduced the amount of flowing clots by about
half after 24 hours. More importantly, use of double
anti-platelet drugs was able to reduce the absolute risk
of stroke by 6% during the first week after a stroke in
patients with narrowed brain vessels.
|
|
Our series of studies established the value of
using simple ultrasound in the community as well in hospital to detect narrowed vessels
in the brain and to identify those with high risk of stroke. Using ultrasound and magnetic
resonance imaging together, we were able to elucidate the mechanism
of stroke in the Chinese and to establish the importance of detecting
small flowing clots in the vessels. The use of double antiplatelet
drug markedly reduced the number of flowing clots in the vessels and
probably prevent further stroke. The results of our studies laid the
foundation for better prevention by identifying high risk patients with
abnormal vessels and for better treatment strategy such as using double
anti-platelet drugs.
The research team on cerebrovascular
disease at the Department of Medicine and Therapeutics,
CUHK: Prof KS Lawrence Wong (front right), Dr Thomas Leung (front left), Dr JH Han (back
left), Mr Edward Shum (back middle), and Dr WH Lin (back right).
Prof Ka Sing Lawrence WONG
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
ks-wong@cuhk.edu.hk
|